we global targets. strategy, and announced financial partnerships open we and I today’s joining for executing including our and opportunities thanks call update on financial will medical up global our discuss to your acquisitions, our the and and On After XXXX long-term full-year growth everyone, that, afternoon, Good then will on Rachel. fourth and Mark an in review will cannabis adult-use our progress the made you, on in growth long-term call more questions. recently results review our provide strategic have Thank markets. quarter for detail us. the
see are such of transformation of We companies supply with We world. multibillion patients, in the in $XXX Taking the as long-term believe of on of the leader continues the billion brands industry. confidence delivering over best-in-class Tilray governments chain, dollar advantage stages a that platform, powered the Tilray’s of by market we portfolio early and future the defining still earning packaged global consumers worldwide around be win trusted will by our multinational the global focus goods consumer of and industry, on to being the to company. team potential the a the
and equivalents full-year year-over-year both our us other we’re a constraints from supply suppliers. with standards, Revenue increased quality that across chain Canada million. increased our We basis. And XXX% US$XX.X sold our momentum. to results, on have to year-over-year total pressure cannabis on forcing for pleased meets kilogram created this source pricing and sequentially achieved Focusing growth despite that growth
we’ve States multiple as markets than see equilibrium orders months, supply larger XX magnitude there government between and are The adult-use in newly deploy cannabis, To most U.S. the up believe paths United growth we markets both promising growth. in next and global will just where potential and to markets greatest in catch European oversupply, as seen opportunities medical Tilray an will demand. legal find pursue capital Canada. and operators to on of the regulators Over to we and capitalize certain be states race
and investments the Europe. the So, expect U.S. on majority of while continue an Canada we to for will market be focus us, future important to
long erode in term, or overpriced as assets we medium to supply be what in normalizes. believe to in invest Canada, We which market in will the believe will not the purchase we value
the As drivers to performance generate global that returns communicated we expect our as grow. remains we to top-line strong growth strategy six on continues business have focused previously,
sixth, First, medical division pioneer a rigorous industry we expand scale differentiated partner with and that this on companies. our investing world’s third, leading as include research of to scale; of strategic acceptance and a fourth, increase development, alliance and fifth, recent production distribution build brands one and with focus Novartis, and capacity of a diverse community maintain distributors market; our strategy, growing and products second, and with governments; the fostering established quality by to rapidly mainstream the patients of serve of faster; by further retailers with appeal inventory the the in clinical consumers; to portfolio our In market a global products our addressable innovation, medical and partnerships global of pharmaceutical line future and a research. finally Sandoz, the set
patients globally Canada. focused distributing global on this increases for year, Our medical on And new next cannabis countries a at half through in In the the original across dozen we least this Sandoz. and partnership with need a agreement was world. access deal to global scale anticipate more medical legitimizes cannabis a
We $XX in total InBev also deep each $XXX to up company The a in our with million, AB THC formed up products. a CBD. combines a of for beverages to million. joint XX-XX strategic beverages cannabis experience containing and to InBev’s intends to expertise invest research partnership non-alcohol venture with AB And
that to JV in and onset pleased already performed that the are duration to we research the are for and have appointed a beverages. time report Tilray for leveraging has We CEO
more of initially agreement focus extensive Group, well CBD on network as The ABG, across the North sharing as their most portfolio world’s Canada restrictions. And in partnership United will due today and Europe and products and in XX Authentic and Brands States in retail products THC interesting products brands, opportunities the The the revenue U.S. packaging far iconic globally with distribution consumer long-term to to more permit. America. branding branding designed a branding and as is the partnership expand of ABG’s Canada. Our in leverage CBD around we the OTC are will than regulations opportunity than
Additionally, Harvest maintaining distribution acres of its foods production, The manufacturing, farmers the and America leading a gives the is they we’re products some trust, new already that consumers seed-to-shelf hemp-derived closed in core more Manitoba as acquisition under remain of relationships US$XXX at so plant acquisitions is distributors growth supply a month, and the control acquisition and Harvest, as world’s as marketing and with across by going of excited as U.S. focus look with why foods when Harvest of we and quality, Canada, strategy. established look Manitoba other retail retailers brands Canada to hemp across distributes has company approximately over partner chain revenue, Last CBD largest than Manitoba ABG. the hemp, to and Manitoba distributors largest well locations more and Harvest leveraging access our brands of we THC, know for North Harvest million the XX,XXX million. well of the and and global want products. to products hemp with distributing of net CBD mergers its nearly forward natural who Strategic C$XXX retailers than producer relationships XX,XXX which in U.S. capabilities, brand forward. to with gross We Manitoba Tilray
in Natura products. supply as we million. company our from will cannabis The Ontario, in Leamington, We to also us with rebranded market approximately further a expand federally High have branded increased acquired recently Gardens, for adult-use Canadian Inc., licensed which Natura, Holdings, market Naturals C$XX cannabis allow based share Park cultivation the high-quality
deliver a ROSE in our December, Finally, in and agreement recent to our as have opportunities our we emphasis Lifescience our we and disruption distribution portfolio invested Quebec. C$X.X Quebec-based supply, demonstrate long-term our markets. growth our million in believe, the exclusive strategic of acquisitions diversification products adult-use under sale, of and cannabis critical We and of for marketing expand brands producer addressable global partnerships global on industries
at and a Chief Sachs managing approach, disciplined key over director remains Andrew we Officer, covered that served where joined strategic investments years. growth us Last sustainable industry. M&A Pucher support Our to as Andrew has as team week, the our Canadian overseeing he investments. recently we announced achieve cannabis Corporate corporate to the making our several next expect Development the most Goldman in previously
we make We’re our excited he will about growth. accelerate as the contributions
our technologies, and R&D Going continue strategic that new increases to M&A territories, us brand opens expect pursue our increases offerings brings invest forward, capacity, to we we in will factors, form distribution. selectively innovative through retail
more our Europe a hemp-derived capitalize Bill the than an brands in Farm believe presents increased important with larger they on building We Tilray extend an in As people for products The represent where put, earlier, the lot changed of tied we legalization on excellent battle significantly closer are company cannabis the the I every billion long is the U.S., we and the has focus believe, to believe in In a that in international the where of of is that markets field are realize. Tilray I U.S. US$XX to we other industry U.S. federal goal most is over the term. and we U.S. a Tilray are said market making leaders the U.S. that can for to to fact opportunity term. legal. CBD them a building potential estimated industry going Simply be portfolio and beyond long-term long among Canada. for opportunity our Europe, and
through the We’ve Authentic Manitoba America. branded U.S. across wellness the produce acquisition the CBD regulations the have United products We for the supply place Brands Harvest CBD CBD source a Canada to of to in derived supply also finalized deal North CBD products medical States and as agreement for infused LiveWell from Group and China CBD Tilray in hemp permit.
We In leadership additional second begin Tilray of for the to U.S. LiveWell partnerships about to make product strategic announcements to quarter investments XXXX. us months, position expect long-term coming during and to the shipping the in we expect market. the in the
Europe. on Focusing
medical legalize. XX XX can and countries, we see end easily increase and ended a how Just the European We began XX, of states and we World XXXX. month, year having grows legitimizing recommendation similar the decision encourage will to Organization’s passed XX parliament to other or XXXX countries this Health the the to legalized access that And globally the to resolution to medical with to with number industry. use cannabis, further by leave last
are we this And the successful market well-positioned Our EU as countries EU campus to Portugal that in more earlier serve harvest medical month. legalize. completed
the hedge to EU, EU for vertically an local, important expect having regulatory in against risk. to the costs produce chain reduce is presence that supply and and a integrated us campus believe cannabis and EU the for distribute We differentiator
months. processing, By distribution a was harvest coming expect sites and significant increase and feet, Our milestone campus end to labs, of approximately X.X includes compared packaging greenhouse the indoor, the well This we to the for as On cultivation ability our to first harvests double as for products. sites, properties, have expand million Company feet. outdoor the and to in research multiple XXXX, medical we total million expect XXXX. square production our our to production X.X we space existing of the space square end
the to our are facilities world significantly Our around production increasing output XXXX. production seven compared global
of us the Board near market becomes do available. Flower, Longer Westleaf, we months to over international From The business, and XX quality balanced small aid Canada, of the our investments will consists board to and taken we few industry. the to Directors. retail advisory including of a with Fire will the and aggressively board more While with the change Tilray as we’re minority leaders remains years. invest the team provide have supply, strategic come. allowing as for over in term, Inner confident, executive we supply-demand believe become supply our our Canadian future the our we and time, formed not in be term business challenged government more in To provide expansion, internationally insights so & advisory farming to we continue have growth in are to additional perspective an global renowned supply strategy perspective, expect strategic steps in not to who disruption next pioneer Spirit
leadership also to our organizations have world strategic team future from and we global earlier, expanded internationally. class executive hires development growth our mentioned teams spearhead As with senior six our existing help
Charlie us to Coca-Cola, deeply and of Cain, our Vice Diageo Redler industry is examining of Corporate team Chief Greg fourth addition committed Goldman Vice differentiator President new Initiative markets. awareness medicine the to the in of in accelerated our Human Most This we joined we for international Sascha competitive for Rita partnered and Starbucks and Sachs, quarter, Executive from Nestle who Therapeutics President published in Dara being and General our culminated from remains President Counsel, be Officer as Cannabinoid from be this year. joins hired the at Retail a recently, results researchers joined complete are Executive from a clinical to with of of future research. Seguin, In to Operations. trial awareness, cognitive the as Vice from from the Director, At function. same Mielcarek, the cannabis Andrew Resources. Managing at the The positive driving University effects Europe, in our has XXXX study of cannabis Grünenthal. sometime well very our as of time, Pucher, as joined medical our important joined Christopher study on the phase to expected Sydney Lambert Development
in Canada; Launching regions; over in in strategic team; and Parks Tilray’s continue summary, new next permit; incredibly pharmacy adult-use supply Manitoba adding High offerings the products XXXX, growth sales our cannabis acquisitions from into of milestones: to XXXX United and Looking chains medical ahead product U.S. partnerships recruiting we balance as and facility additional in products existing markets pharmaceutical expanding and to years. Tilray to partnerships excited in products expanding to in international currently several following in the shipping countries; processing serve; achievements management our strengthen Europe. our for additional about anticipate exporting trials; license of In and to and countries the finally, clinical our proud Tilray’s London, potential industry CBD agreements year Ontario; obtaining Canada; further and Tilray outside corporate medical to the a Harvest regulations additional are signing the of the we are additional the executives States the we
We over world. employees to our will turn the will and our and for strategic around our continue that, fuel long-term the customers, that patients take Mark. value as initiatives actions call I well as to execute consumers, With like shareholders, would on to
